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Apicomplexa are unicellular eukaryotic pathogens
that carry a vestigial algal endosymbiont, the apico-
plast. The physiological function of the apicoplast
and its integration into parasite metabolism remain
poorly understood and at times controversial. We
establish that theToxoplasmaapicoplastmembrane-
localized phosphate translocator (TgAPT) is an
essential metabolic link between the endosymbiont
and the parasite cytoplasm. TgAPT is required for
fatty acid synthesis in the apicoplast, but this may
not be its most critical function. Further analyses
demonstrate that TgAPT also functions to supply
the apicoplast with carbon skeletons for additional
pathways and, indirectly, with energy and reduction
power. Genetic ablation of the transporter results in
rapid death of parasites. Thedramatic consequences
of loss of its activity suggest that targeting TgAPT
could be a viable strategy to identify antiparasitic
compounds.INTRODUCTION
Plastids are derived from the endosymbiotic integration of a free-
living cyanobacterium into a single-celled protist (Gould et al.,
2008). This single primary endosymbiosis led to the development
of three major autotrophic lineages: the glaucophytes, the red
algae, and the green algae (and their descendants, the higher
plants). Additional lineages are derived from at least three
secondary endosymbiotic events, i.e., the uptake and integration
of a green alga, giving rise to the Euglenophyta and the Chlor-
achniophyta, and the engulfment of a red alga, leading to the
Alveolata, Heterokontophyta, and other groups (Gould et al.,
2008).
While primary plastids are enclosed by two envelope
membranes, which are derived from the inner and outer62 Cell Host & Microbe 7, 62–73, January 21, 2010 ª2010 Elsevier Inmembranes of the Gram-negative cyanobacterium (Cavalier-
Smith, 2000), secondary plastids are surrounded by three or
four membranes. Here, the two innermost membranes are
thought to represent the two plastid membranes of the green
or red algae, the third membrane is a remnant of the red or green
algae plasma membrane, and the outermost membrane is
derived from the host’s endomembrane system. The discovery
of a vestigial plastid surrounded by four membranes in Apicom-
plexa, the apicoplast (Ko¨hler et al., 1997; McFadden et al., 1996),
suggests that this group of protozoan parasites likely evolved
from a photosynthetic ancestor (Moore et al., 2008). Growing
evidence supports the notion that the ancestor of the apicoplast
was a red alga; however, some studies have suggested green
algal ancestry (Gould et al., 2008). Primary and secondary
plastids are the home of photosynthesis, but also perform a
range of additional essential biosynthetic functions. The exact
physiological functions of apicoplasts, in contrast to plant plas-
tids, are not fully understood; however, it is now well established
that the apicoplast is indispensable for parasite survival (Fichera
and Roos, 1997; Jomaa et al., 1999; van Dooren et al., 2009). The
phylum Apicomplexa contains numerous important pathogens,
including the causative agents of malaria and toxoplasmosis.
As the human host lacks plastids, the apicoplast has become
a prime target for the development of new antiparasitic drugs
(Fichera and Roos, 1997; Goodman and McFadden, 2007;
Jomaa et al., 1999). Mining the genome sequences of Apicom-
plexa and subsequent experimental studies have produced
three major candidate functions for the apicoplast, namely the
synthesis of fatty acids, isoprenoids, and heme (Ralph et al.,
2004).
Here, we focus on how the metabolism of the apicoplast is
linked with the metabolism of the parasite cytoplasm. It has
been proposed that the integration of transporters into plastid
membranes was an early important step in endosymbiosis,
allowing the host cell to directly profit from its endosymbiont
(Cavalier-Smith, 2000; Weber et al., 2006). In higher plants,
carbon skeletons from photosynthesis are exported in the form
of triose phosphates by the triose phosphate/phosphate translo-
cator (TPT) (Flu¨gge et al., 2003). The TPTs represent one member
of a larger family of plastid phosphate translocators (pPTs)c.
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inorganic phosphate and phosphorylated C3, C5, or C6
compounds as counter substrates. The TPT is involved in the
export of carbon; in contrast, the other subfamilies catalyze
import of metabolites into plastids, namely phosphoenolpyruvate
(PEP) (Fischer et al., 1997), glucose-6-phosphate (Glc6P) (Kam-
merer et al., 1998), and xylulose-5-phosphate (Eicks et al.,
2002). In the apicoplast, this diversity appears greatly reduced.
Species of the genus Plasmodium possess two different pPTs;
only a single pPT was identified in T. gondii (TgAPT) (Fleige
et al., 2007; Karnataki et al., 2007; Mullin et al., 2006). While the
Toxoplasma APT appears to localize to multiple membranes,
thePlasmodium transporters are believed to differentially localize
to the outer and inner membranes, respectively. The physiolog-
ical functions of the apicoplast phosphate translocators (APTs)
and their role in apicoplast metabolism remain unknown.
Here, we show in Toxoplasma that loss of the APT results in
the rapid death of the parasite. Through biochemical and genetic
analyses, we demonstrate that APT combines the substrate
specificity of plant TPTs and PPTs and is thus able to deliver
carbon skeletons for at least two important metabolic pathways
of apicoplasts. In addition, this transporter likely plays a major
role in delivering redox equivalents and ATP to this organelle.
RESULTS
Construction of Targeting Cosmids by Recombineering
We thought to genetically test the function and importance of
the APT in T. gondii. A number of approaches are available to
modify the parasite genome; however, the efficiency of these
procedures is often low, requiring the screening of large
numbers of transgenic clones. The main reason for this is the
high level of nonhomologous versus homologous recombination
observed in T. gondii (see Striepen and Soldati, 2007 for a
detailed discussion). This can be overcome by employing posi-
tive/negative selection using two independent markers (Mazum-
dar et al., 2006) or by using mutant parasite strains that lack the
end-joining repair mechanism (Fox et al., 2009; Huynh and
Carruthers, 2009). However, thus far these mutants are not suit-
able for the construction of conditional gene deletions. We
wondered if using large flanking sequences to guide recombina-
tion would increase the frequency of homologous replacement
and thus negate the need for multiple markers or lack of end-
joining repair. An arrayed and end-sequenced genome-wide
set of cosmids now provides ready access to large insert clones
of T. gondii genomic DNA (Gubbels et al., 2008), but the large
size of cosmids (45,000 bp) precludes standard restriction-
mediated cloning of targeting constructs. We have therefore
adapted recombineering (Datsenko and Wanner, 2000; Lee
et al., 2001) to modify cosmids into parasite-targeting vectors.
This can be accomplished in a single cloning step, and the
strategy is outlined in Figure 1. We engineered a series of modi-
fication cassettes that allow the construction of epitope tags
and gene deletions. These cassettes contain a gentamycin
resistance marker derived from a bacterial transposon (Poteete
et al., 2006) for selection in bacteria and chloramphenicol or
phleomycin markers for the subsequent selection in T. gondii.
We selected a suitable cosmid covering the TgAPT gene
(PSBYL85), introduced this into the EL250 strain of E. coli, andCelltransiently induced the recombination machinery by heat shock.
We then PCR amplified a targeting cassette using primers
containing 50 bp of gene-specific flanking sequence to guide
recombination into the desired site and isolated recombinants
by double selection using gentamycin and kanamycin. Fig-
ure 1B shows restriction mapping of cosmid PSBYL85 before
(TgAPT) and after recombination of a C-terminal HA epitope
tag (TgAPT-HA) or a deletion of the TgAPT gene (DTgAPT),
respectively. Correct placement of the cassette was also
confirmed by sequencing cosmids using primers flanking the
insertion sites.
Transfection of T. gondiiwith Modified Cosmids Results
in Highly Efficient Gene Targeting
We next tested whether modified cosmids will target the
cassette into the appropriate locus of the parasite genome.
Figure 1C shows a schematic representation of the crossover
event that will result in the insertion of an HA epitope tag at the
30 end of the TgAPT gene. Cosmid DNA (TgAPT-HA) was trans-
fected into RH-HX strain tachyzoites by electroporation, and
parasites were cultured in the presence of chloramphenicol.
Clonal lines were established and tested for gene targeting by
PCR using primers flanking the TgAPT coding region. As shown
in Figure 1E, for all clones tested, the 4756 bp product expected
for successful replacement was obtained, while wild-type (WT)
controls produced a 1435 bp amplicon. Southern blot analysis
using the 50 untranslated region of the TgAPT gene as probe
further supported correct insertion of the cassette. We also
tested the knockin mutant at the protein level and performed
immunofluorescence and western blot analyses using an anti-
body specific to the HA tag (Figure S1). We found labeling of
the apicoplast and a single protein band of the appropriate
size that remains unprocessed, as described previously (Fleige
et al., 2007; Karnataki et al., 2007), consistent with correct
genomic placement of the tag.
TgAPT Is Required for the Activity of the Apicoplast
Fatty Acid Synthesis Pathway
We next engineered a conditional TgAPT mutant. We introduced
an HA-tagged minigene version of the TgAPT gene under control
of a tetracycline-regulatable promoter into the T. gondii transac-
tivator strain (Meissner et al., 2002). The resulting parasite strain
was then transfected with a cosmid in which we had replaced the
TgAPT coding sequence with the chloramphenicol acetyl trans-
ferase (CAT) gene (Figure 1D), and stable transformants were
selected on chloramphenicol. PCR analysis of the resulting
transgenic lines showed that 16 out of 17 clones carried the
deletion, and homologous recombination was confirmed by
Southern blot (Figures 1F and 1H). We cultured this mutant in
0.5 mg/ml anhydrotetracycline (ATc) and measured protein level
by western blot using an anti-HA antibody and found that TgAPT
levels were severely depleted after one day of treatment (Fig-
ure 2A). This swift knockdown is similar to that observed in the
previously isolated acyl carrier protein (ACP) mutant (Mazumdar
et al., 2006), which is shown for comparison (Figure 2B; note that
these are two independent antibody reagents, which might have
slightly different limits of detection). We hypothesized that
TgAPT might import the presumptive precursor molecule for
apicoplast fatty acid synthesis (FASII), PEP (Mazumdar andHost & Microbe 7, 62–73, January 21, 2010 ª2010 Elsevier Inc. 63
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Figure 2. Genetic Ablation of TgAPT Results in Loss of Apicoplast FASII-Dependent PDH-E2 Lipoylation
(A and B) Western blot analyses of TgAPT and ACP mutant after 0–4 days of ATc treatment (TgAPT mutant could be analyzed for only 3 days due to parasite
death). The product of the regulated minigene is detectable in the absence of ATc (using an antibody against the HA epitope [A] or ACP [B]) and shows a severe
reduction within 24 hr. Extracts of equal numbers of parasites (53 106) were loaded, and GRA8 serves as loading control. We also probed steady-state levels of
lipoylated PDH-E2 with a lipoylation-specific antibody and found that levels are reduced in both mutants in response to ATc treatment.
(C and D) Pulse-chase analysis of PDH-E2 lipoylation. Levels of newly synthesized lipoylated PDH-E2 are severely reduced in the TgAPT and ACP mutants after
1 or 2 days, respectively. Lipoylation of mitochondrial E2 enzyme subunits (mito-E2) is not affected in either mutant. Human PDH and mitochondrial E2 subunits
(a contamination from the human host cell) (Crawford et al., 2006; Mazumdar et al., 2006; van Dooren et al., 2008) are marked by an asterisk. This experiment
uses an antibody that recognizes all lipoylated proteins (we demonstrate that the 92 kDa lipoylated protein represents the apicoplast PDH-E2 through immuno-
precipitation experiments using a specific antibody; see Figure S2). P, pulse; C, chase.
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The Toxoplasma Apicoplast Phosphate TranslocatorStriepen, 2007; Ralph et al., 2004), into the apicoplast. Currently,
there is no suitable assay available to directly measure the
activity of apicoplast FASII in T. gondii. However, in previous
work we have shown that the activity of the FASII pathway
can be measured indirectly by following the lipoylation of the
apicoplast pyruvate dehydrogenase E2 subunit (PDH-E2) using
lipoylation-specific antibody reagents (Mazumdar et al., 2006).
PDH-E2 lipoylation depends on two apicoplast-resident
enzymes, LipA and LipB, and uses FASII-derived octanyl-ACP
as substrate (Crawford et al., 2006; Cronan et al., 2005; Mazum-
dar et al., 2006; Thomsen-Zieger et al., 2003). Western blot
analysis of the TgAPT mutant grown in the presence of ATc
shows a marked drop in the steady-state level of lipoylatedFigure 1. High-Frequency Targeting of the Parasite Genome Using Mo
(A) Schematic representation of cosmid engineering using a gene replacement ca
added to the ends by PCR.
(B) RsrII Restriction mapping of cosmid PSBYL85 before (TgAPT; predicted res
recombineering with cassette pHcG (TgAPT-HA; 18,280, 11,852, 11,146, 6,02
respectively. Diagnostic restriction fragments for the parental cosmid (arrowhea
(C and D) Schematic representations of homologous recombination events in the
Diagnostic PCR products and restriction fragments for the native and modified T
(E and F) PCR analysis of clones derived from a stable chloramphenicol-resistant
WT control.
(G and H)Southernblot analysisofparasite mutantclonesalong withRH, RH-HXGPR
of the tet-regulatable promoter). Blots were probed with a 600 bp fragment of the TgA
CellPDH-E2 over the course of the treatment, comparable to that
seen in ACP mutant controls (Figures 2A and 2B). Genetic inter-
ference with apicoplast metabolism or protein import has been
shown to result in biogenesis defects and subsequent loss of
the organelle (Agrawal et al., 2009; Mazumdar et al., 2006; van
Dooren et al., 2008). To ensure that the loss of PDH lipoylation
observed here was not the trivial consequence of organelle
loss, we quantified apicoplasts using an imaging assay. As
shown in Figure S3, no significant organelle loss is detectable
over the 3 days of ATc treatment used in all other experiments.
To measure the rate of synthesis of lipoylated PDH-E2 in
response to ATc, we used a highly sensitive pulse-chase assay
(van Dooren et al., 2008). Parasites were labeled with 35S aminodified Cosmid Clones
ssette as example; homologous recombination is guided by a 50 bp sequence
triction fragments are 18,280, 11,852, 11,146, 2,635, and 2,490 bp) and after
8, and 2,490 bp) and pICG (DTgAPT; 22,407, 11,852, 11,146, and 2,490),
d) and modified cosmid (double arrowhead) are highlighted.
T. gondii genome for cosmid-based genome tagging (C) or gene disruption (D).
gAPT locus are highlighted.
population after transfection with modified cosmid DNA. RH strain is shown as
T, and parental iTgAPT-HA strain (TATi strain withTgAPT minigene under control
PT 50 untranslated region as indicated. Maps shown in this figure are not to scale.
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Figure 3. Parasites Lacking TgAPT Show a
More Pronounced Growth Defect Than
Parasites Lacking Apicoplast FASII
(A) Fluorescence growth assay of the TgAPT
mutant in the presence and absence of ATc. (A
dTomato-RFP reporter was introduced by trans-
fection, and stable transformants were isolated
by flow cytometry as previously described [van
Dooren et al., 2008]. Each data point represents
the mean of six wells, and the error bar gives the
standard deviation.)
(B) Confluent host cell cultures were infected
with 400 tachyzoites of various parasite strains
(as indicated) and incubated for 10 days in the
absence and presence of ATc. Cells were fixed
and stained as described (Striepen and Soldati,
2007). Assays were performed in duplicate flasks,
and plaque areas were measured by image
analysis after scanning.
(C) Areas are shown as whisker plots providing the
mean and 1.5 times the interquartile distance as
the box. Statistical significance was evaluated
using the unpaired t test. No ATc, white boxes;
plus ATc, hatched boxes. No plaques were
observed in the ATc-treated APT mutant.
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bel-free media for 3 hr (chase). Lipoylated proteins were isolated
from parasite lysates by immunoprecipitation and analyzed by
gel electrophoresis and autoradiography (Figures 2C and 2D).
In the absence of ATc, PDH-E2 lipoylated during the chase
period can be clearly detected in the TgAPT and ACP mutants.
ATc knockdown results in loss of de novo PDH lipoylation in
the TgAPT mutant after 1 day and in the ACP mutant after 2
days, respectively. Note that ATc treatment of WT parasites
has no effect on lipoylation (Agrawal et al., 2009; Mazumdar
et al., 2006; van Dooren et al., 2008).
We conclude that metabolites transported by TgAPT are
essential for PDH-E2 lipoylation and hypothesize that this is due
to the lack of the required precursor, a product of the apicoplast
FASII pathway.
Loss of TgAPT Results in Rapid Death of Parasites
Apicoplast FASII is essential for the growth of T. gondii (Mazum-
dar et al., 2006). One would therefore expect the transporter
supplying FASII with substrate to be equally essential. To test
this, we introduced a red fluorescent protein gene into the
mutant strain and recorded fluorescence intensity as a measure
of growth. As shown in Figure 3A, ATc treatment results in negli-
gible growth of the mutant strain when compared to untreated
control, consistent with a block of the essential FASII system.
Furthermore, this growth impact appeared remarkably fast
when compared to the previously engineered apicoplast FASII
mutant (Mazumdar et al., 2006). We directly compared the66 Cell Host & Microbe 7, 62–73, January 21, 2010 ª2010 Elsevier Inc.TgAPT with the ACP mutant in parallel
plaque assays (Figures 3B and 3C). As
previously reported, knockdown of ACP
results in marked reduction of plaque
size. In contrast, in the TgAPT mutant,
we did not observe any plaque formation.We noted that the TgAPT mutant shows a reduction in growth
already in the absence of ATc. We wondered if this might be
due to secondary mutations or to lower activity of the ectopic
transporter (e.g., due to the C-terminal epitope tag [see below],
inappropriate expression level, or timing from the tet-regulated
promoter). To test this, we introduced a TgAPT minigene carrying
an N-terminal Ty-1 tag under control of a constitutive promoter
into the mutant background using a BLE marker and phleomycin
selection. This strain shows restored growth, arguing against
unspecific secondary mutations (Figures 3B and 3C). In fact, in
both the parental and the complemented strain, ATc treatment
results in improved growth, suggesting that the C- but not the
N-terminally tagged transporter exerts a slight dominant-nega-
tive effect (pPTs usually are homodimers; additional fluores-
cence-based growth data produce similar results and are
provided in Figure S4). To exclude that the fast death of the condi-
tional APT mutant was due to crippling resulting from a C-ter-
minal-regulated copy of APT, we reengineered this mutant, start-
ing with an N-terminal-regulated ectopic APT gene. As shown in
Figure S5, this mutant dies as fast as the previous mutant, sug-
gesting that death is a direct consequence of loss of APT.
We next asked if the TgAPT mutants simply grow extremely
slowly or if they suffer more pronounced defects that result in a
swift death of the parasite. A frequently used measure of cellular
viability is the energetic state of the mitochondrion and, more
specifically, its membrane potential. We measured parasite
mitochondrial membrane potential using 5,50,6,60-tetrachloro-
1,10,3,30 tetraethylbenzimidazolylcarbocyanine iodide (JC-1).
Figure 4. TgAPT but Not ACP Mutant Shows Dramatic Loss of Mitochondrial Membrane Potential
(A) Fluorescence microscopy of JC-1-labeled parasites shows accumulation of green fluorescent dye in the cytoplasm and the formation of red fluorescent
J-aggregates in the mitochondrion. This red fluorescence is abolished when parasites are treated with ionophores (valinomycin [+VM] is shown here).
(B) TgAPT and ACP mutants were treated for 0–3 days with ATc, labeled with JC-1, and analyzed by flow cytometry. Untreated parasites show bright green
and red fluorescence. Sustained ATc treatment leads to a pronounced decline in red fluorescence in the TgAPT mutant, but not the ACP mutant, over the
observation period.
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accumulates in the mitochondrion to concentrations that result
in the formation of red fluorescent J-aggregates (Cossarizza
et al., 1993). Mitochondrial accumulation depends on an intact
membrane potential. JC-1-labeled parasites showed green
fluorescence in the cytoplasm and red fluorescence in the mito-
chondrion that was dissipated by CCCP and valinomycin treat-
ment (Figure 4). We measured the effect of ACP and TgAPT
knockdown on the mitochondrial accumulation of JC-1 by flow
cytometry after 0–3 days of ATc treatment. We did not observe
a significant change in the ACP mutant. However, we note
a dramatic drop of mitochondrial fluorescence in TgAPT knock-
down parasite (56.6%, compared to 73.2% and 79.9% with the
strong uncouplers valinomycin and CCCP). We conclude that
loss of TgAPT leads to a significantly more severe phenotype
than loss of ACP, suggesting that TgAPT likely supports essen-
tial apicoplast functions beyond the FASII pathway.
Transport Characteristics of Heterologously
Expressed TgAPT
To identify potential pathways supplied by TgAPT, we next
sought to establish the molecules that are imported by this trans-
porter into the apicoplast. As the apicoplast cannot be purified in
sufficient quantity and purity, we expressed TgAPT heterolo-Cellgously in yeast and reconstituted the transport activities in lipo-
somes (Hanke et al., 1999). The entire TgAPT coding sequence
was introduced into the yeast expression vectors pYES-N and
pYES-C, thereby adding a 63 His tag to the N and C termini of
TgAPT, respectively. The TgAPT constructs were used to trans-
form yeast cells, and several clones were tested for TgAPT
expression by western blot analysis using an antibody directed
against the His tag (data not shown).
In a first experiment, the phosphate transport activities of both
the N- and C-terminal fusion proteins were determined. We noted
that the specific activity of the TgAPT-C protein was less than
30% of the activity of TgAPT-N (data not shown). We conclude
that C-terminal tagging impedes optimal transporter function,
a finding that is consistent with our in vivo data in parasites. There-
fore, only the TgAPT-N protein was used for further experiments.
Substrate specificities of TgAPT were determined by mea-
suring the transport of radiolabeled Pi into proteoliposomes
preloaded with different counter-exchange substrates. These
data are shown in Table 1 in comparison with the substrate
specificities of pPTs from higher plants and a red alga. Evidently,
the TgAPT protein equally accepts inorganic phosphate and
phosphoenolpyruvate (PEP) as substrates and, to an even higher
extent, triose phosphate and 3-phosphoglycerate (3-PGA). In
contrast, glucose-6-phosphate (Glc6P) (Table 1) and other sugarHost & Microbe 7, 62–73, January 21, 2010 ª2010 Elsevier Inc. 67
Table 1. Substrate Specificities of Recombinant Plastid Phosphate Translocators from T. gondii, the Red Alga Galdieria sulphuraria,
and Land Plants
Recombinant translocator proteins
TgAPT Translocators from other species Kinetic constantd
Substratea WT K67A K145A K310A GsTPTb GsPPTb SoTPTc BoPPTc PsGPTc TgAPT
Phosphate 100 21 ± 2 0 ± 2 0 ± 1 100 100 100 100 100 KM 1.39 ± 0.28 mM
Triose phosphate 192 ± 50 19 ± 3 0 ± 3 0 ± 2 87 25 92 22 112 Ki 1.63 ± 0.26 mM
3-PGA 167 ± 34 23 ± 3 1 ± 1 0 ± 2 25 22 90 16 50 Ki 1.33 ± 0.49 mM
PEP 99 ± 16 17 ± 2 0 ± 2 0 ± 1 20 90 5 72 20 Ki 1.65 ± 0.52 mM
Glucose-6-P 25 ± 5 1 ± 3 0 ± 1 0 ± 1 25 15 5 2 90
a Liposomes were preloaded with 20 mM substrates as indicated. Transport activities are given as percentage of the Pi/Pi counter-exchange set to
100%. Mean values are from at least three different experiments.
b Data are from Linka et al., 2008.
c Data are from Kammerer et al., 1998; Spinacea oleracea, So; Brassica olerace, Bo; Pisum sativum, Ps.
d Mean values (±SEM) are from 4–6 different experiments.
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shown), are not transported by the TgAPT. These data are
corroborated by measurements of the apparent kinetic constants
of TgAPT for the abovementioned substrates (Table 1). The KM
(app) for inorganic phosphate is 1.39 mM, similar to the KM values
of the plant transporters, which are in a range between 0.8 and
1.1 mM (Fischer et al., 1997; Kammerer et al., 1998). The Ki
values, i.e., the apparent constants for competitive inhibition,
for the other substrates transported by TgAPT are in the same
range as the KM for phosphate, with Ki values of 1.63, 1.33, and
1.65 mM for triose phosphate, 3-PGA, and PEP, respectively. In
contrast, Glc6P and other hexose phosphates are only poorly
transported by TgAPT under the experimental conditions. Under
physiological conditions in which the hexose phosphates have to
compete with the other phosphorylated substrates, these metab-
olites are likely not transported at all. Thus, the TgAPT represents
a pPT with a remarkable substrate specificity not found in pPTs
from plants and algae, transporting triose phosphates and
3-PGA, i.e., metabolites phosphorylated at carbon 3, and PEP,
which is phosphorylated at position 2.
Lysine Residues Conserved across Phosphate
Translocators Are Critical to TgAPT Activity
In Vivo and In Vitro
To begin to dissect the molecular basis of the unique substrate
specificity of TgAPT, we established a complementation assay
to test mutant versions of the transporter in vivo. We subcloned
a WT version of the TgAPT coding sequence into a construct
that results in N-terminal fusion to a Ty-1 epitope tag and
a FKB12 destabilization domain (DD). We introduced this domain
to allow for conditional modulation of protein levels using Shield-
1 (Banaszynski et al., 2006; Herm-Go¨tz et al., 2007) in case point
mutants should exert dominant-negative effects. We introduced
this plasmid stably into the mutant background using phleomy-
cin selection and demonstrated by immunofluorescence that
the protein is expressed and correctly targeted to the apicoplast
(Figure 5B). Measuring protein levels by western blot, we noted
that despite the presence of a DD domain, the protein was stable
in the absence of Shield-1 (Figure S6). This might be due to poor
destruction of multipass membrane proteins or to the fact that
TgAPT localizing to the inner membranes of the apicoplast might68 Cell Host & Microbe 7, 62–73, January 21, 2010 ª2010 Elsevier Inbe protected from proteasomal degradation. Importantly, WT
TgAPT fully restores growth of the mutant under ATc in the
presence or absence of Shield-1 when measured by plaque or
fluorescence assay (Figures 5F and 5J).
Several lysine residues are highly conserved in a wide range of
members of the drug/metabolite transporter superfamily,
including TgAPT (Flu¨gge et al., 2003; Karnataki et al., 2007;
Knappe et al., 2003; Martin and Kirk, 2004). These positively
charged residues are believed to interact with the negatively
charged substrates and are therefore thought to be critical for
substrate recognition and transport activity (Knappe et al.,
2003). To directly test this hypothesis, we engineered three
lysine-to-alanine point mutations (K67A, K145A, and K310A)
and introduced them into the TgAPT mutant. All three mutants
are expressed at levels comparable to the WT transgene, and
the proteins are correctly targeted to the apicoplast (Figures 5
and S6). We next tested the growth of these mutants by fluores-
cence and plaque assays in the absence and presence of ATc
and Shield-1. We find that K145A and K310A fail to complement
under ATc, regardless of the presence of Shield-1. Interestingly,
mutant K67A displayed a Shield-1-dependent phenotype. In the
presence, but not the absence, of Shield-1, growth of the mutant
is restored. We next wanted to correlate these in vivo observa-
tions with the transport capabilities of the mutant proteins.
Mutant TgAPT proteins were heterologously expressed and
tested in reconstituted liposomes (Table 1). Mutations K145A
and K310A abolished transport activity, while mutation K67
reduced the activity to about 10%–20% for all transport sub-
strates tested. It appears that this partial attenuation of transport
efficiency is responsible for Shield-1 dependency of comple-
mentation in vivo. The exact molecular mechanism underlying
this phenomenon (subtle differences in expression level or addi-
tive effects of point mutants and DD destabilization) remains to
be defined. We conclude that residues implicated in substrate
binding are key in mediating transporter activity of TgAPT both
in vivo and in vitro, suggesting that substrate selection is vital
for the correct functioning of this apicoplast membrane trans-
porter. We note that transport activity in vitro and biological
complementation in vivo are highly consistent, making this an
ideal system for further mechanistic dissection of this transporter
and its function in apicoplast metabolism.c.
Figure 5. Identification of Lysine Residues Critical for TgAPT Activity by Mutational Analysis and In Vivo Complementation Assay
(A–E) A DTgAPT/iAPT-HA mutant clone carrying the dTomato-RFP marker was transfected with the WT APT coding sequence expressed from a constitutive
promoter carrying an N-terminal Ty-1 epitope tag (Ty-WT), the same transgene carrying in addition a FKB12 destabilization domain (DD-Ty-1-WT), and three point
mutations of the latter (DD-Ty-1-K67, -K145, and -K310A, respectively). Immunofluorescence assays (A–E) show parasites cultured in the presence of 0.1 mM
Shield-1 for 36 hr and subsequently labeled with antibodies to the Ty-1 epitope tag (green) and the apicoplast-resident protein Cpn60 (red; note that cytoplasmic
red background fluorescence is due to residual dTomato-RFP autofluorescence after fixation). Transgenic parasite strains are as indicated.
(F–I) Plaque assays of indicated strains grown in the absence (ATc) or presence (+ATc) of 0.5 mg/ml ATc or in the presence of ATc and Shield-1 (+ATc +Shld1).
(J–M) Fluorescence growth assays. Circles, ATc; triangles, +ATc; squares, +ATc +Shld1 (each data point represents the mean of six wells, and the error bar
gives the standard deviation).
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T. gondii possesses a single protein that shows significant simi-
larity to plant pPTs and that is located in the apicoplast envelope
membranes (Fleige et al., 2007; Karnataki et al., 2007) (Figure S1).
By heterologous expression of the TgAPT gene in yeast and
reconstitution of the encoded protein, we showed that the
TgAPT is able to transport triose phosphates, 3-PGA, and
PEP, but does not possess Glc6P transport activity. With the
substrate specificities of the single Toxoplasma phosphate
translocator presented here, several conclusions can be drawn
with respect to its evolution and physiological functions.
TgAPT Is the Source of Carbon for Essential
Apicoplast Anabolic Pathways
Our biochemical analyses indicate that TgAPT is capable of
exchanging triose phosphate and PEP for inorganic phosphate.
This leads to a net import of carbon into the apicoplast to be used
for anabolic pathways (Figure 6). Through genetic ablation, weCelldemonstrate that TgAPT is required for the activity of the apico-
plast FASII pathway, thus providing a direct link between
cytoplasmic and apicoplast metabolism. However, as we show
here, loss of TgAPT results in a significantly more severe pheno-
type than loss of FASII alone. Taken together with recent genetic
studies on FASII in Toxoplasma and Plasmodium, this suggests
that the production of fatty acids is likely not the primary meta-
bolic role of the apicoplast. In Plasmodium, FASII was shown
to be dispensable in the blood and insect stages but essential
in the liver stage, and in T. gondii, while clearly essential, ablation
of the pathway results in delayed effects on growth (Mazumdar
and Striepen, 2007; Mazumdar et al., 2006; Vaughan et al.,
2009; Yu et al., 2008). A second pathway likely depending on
TgAPT imported substrates is the DOXP isoprenoid synthesis
pathway (Figure 6). Comparative genomic analyses across the
Apicomplexa find this pathway to be conserved in all apico-
plast-bearing species, while FASII and heme synthesis have
been lost in Theileria and Babesia (Brayton et al., 2007; Gardner
et al., 2005). The recent discovery of an important role for theHost & Microbe 7, 62–73, January 21, 2010 ª2010 Elsevier Inc. 69
Figure 6. TgAPT Links Apicoplast Metabolism to the
Parasite Cytoplasm
Schematic representation of apicoplast key anabolic path-
ways (note that this is a highly simplified outline and that the
number of arrows does not reflect the number of enzymatic
steps needed). Note that TgAPT serves as a hub to supply
carbon (through PEP and triose phosphate) as well as energy
and reduction power through the triose shuttle. TgAPT is a
phosphate antiporter, and Pi is not shown for simplicity.
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intriguing candidate for a parasite molecule that might depend
on apicoplast-derived isoprenoids (Nagamune et al., 2008).
Inhibition of the rate-limiting step of the DOXP pathway with
the antibiotic fosmidomycin results in inhibition of Plasmodium
in culture and cure of the infection in animal models and human
clinical trials (Jomaa et al., 1999; Oyakhirome et al., 2007).
Surprisingly, however, Toxoplasma and Theileria appear to be
highly resistant to fosmidomycin (Clastre et al., 2007; Lizundia
et al., 2009). While this might suggest that this pathway is not
essential in these parasites, our data raise alternative explana-
tions. Based on the TgAPT mutant phenotype and the compara-
tive genomic data, we hypothesize that fosmidomycin resistance
in T. gondii is more likely due to differences in the target enzyme
DOXP reductoisomerase or differences in drug import into the
parasite or the apicoplast. Clearly, more work is needed to
discern these models. The genetic and biochemical approaches
developed in the current study should provide the necessary
tools to address this important question.
Triose Phosphate/3-PGA Exchange Can Provide
Energy and Reduction Equivalents
for the Toxoplasma Apicoplast
The apicoplast has lost its ability to photosynthesize during the
adaptation of its host to parasitism. This required adaptations
of the flow of energy and carbon between endosymbiont and
host, reflected in the transporter. With the import of triose phos-
phates into the apicoplast, their conversion to 3-PGA, and
subsequent export of 3-PGA, a triose phosphate/3-PGA shuttle
is constituted that now likely runs in the opposite direction when
compared to plants (Figure 6). All necessary components
required for such a shuttle are expressed in T. gondii, namely
cytosolic and plastid isoforms of phosphoglycerate kinase,
GAPDH, triose phosphate isomerase, and the TgAPT linking
them (Fleige et al., 2007). This shuttle results in a net transfer
of ATP and reduction power from the cytosol to the apicoplast.
GAPDH and PDH are the only biochemical processes identified
in the apicoplast producing reducing equivalents in the form
of NADH or NADPH, while the phosphoglycerate kinase and
pyruvate kinases are the only enzymes producing ATP. The
importance of the triose phosphate/3-PGA shuttle is reflected70 Cell Host & Microbe 7, 62–73, January 21, 2010 ª2010 Elsevier Inc.in the transport characteristics of the TgAPT.
When compared to plant transporters, TgAPT
shows an unusually high relative transport rate of
triose phosphates and 3-PGA, which are 190%
and 172% of the phosphate transport rate. Strik-
ingly, while the T. gondii genome encodes two
GAPDH genes, of which one is of red algal originand likely apicoplast targeted (Fast et al., 2001; Fleige et al.,
2007), in Plasmodium only a single GAPDH is apparent from
the genome sequence, and the protein appears to be localized
to the cytosol (Daubenberger et al., 2003). This suggests
important differences in the apicoplast metabolism between
the two parasite species.
Evolution of the Toxoplasma Phosphate Translocator
Toxoplasma has a phosphate translocator that uniquely
combines the substrate specificities of a TPT and a PPT. None
of the phosphate translocators from algae and higher plants
have the ability to transport C3 compounds phosphorylated at
both carbon 2 and 3. In higher plants, four specialized subfamilies
of transporters have evolved to enable exchange of carbon with
the chloroplast (Flu¨gge et al., 2003), and a survey of green algal
genomes indicates that they share three of these pPT subfamilies
(K.F., unpublished data). In contrast, the red alga Galdieria sul-
phuraria possesses only a TPT and a PPT (Linka et al., 2008).
Equivalent transport activities have also been detected in the
plastid of the cryptophyte Guillardia theta, which is also derived
from red algae by secondary endosymbiosis; however, these
activities have not yet been assigned to a particular protein
(Haferkamp et al., 2006). Given the presence of both a PPT and
TPT in red algae, it is likely that the ancestor of the apicoplast
inherited multiple specific pPTs. Over time, likely driven by the
biochemical and genomic consequences of losing photosyn-
thesis, some pPTs were lost, and others experienced a broad-
ening of substrate specificity. Analysis of pPTs in apicomplexan
relatives such as dinoflagellates and the recently discovered,
early-diverging photosynthetic apicomplexan Chromera prom-
ises to illuminate the evolution of pPTs in the Apicomplexa.
Both red algae and Apicomplexa lack transporter for Gl6P and
other hexose phosphates.
TgPT Is an Essential Part of the ToxoplasmaMetabolism
The TgAPT delivers carbon units for at least two different
anabolic processes in the apicoplast, FASII, and likely the
DOXP pathway. In addition, it has an essential role in indirectly
supplying the apicoplasts with ATP and redox equivalents.
Thus, TgAPT is a metabolic hub that links cytosolic metabolism
with essential processes in the apicoplast. In support of this
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in the rapid death of the parasite. The unique substrate specificity
of this transporter, combined with the dramatic consequences of
loss of its activity, suggests that targeting TgAPT could be a viable
strategy to identify antiparasitic compounds. Apicoplast path-
ways—in particular, the FASII and DOXP pathways, which both
are of cyanobacterial origin—are already intensely pursued for
drug development (Goodman and McFadden, 2007; Wiesner
et al., 2008). However, several apicoplast-directed pharmaco-
logical and genetic manipulations have yielded slow inhibition
kinetics, a phenomenon that has been dubbed delayed death
(Fichera and Roos, 1997). Such slow kinetics might limit potency
and could potentially favor the development of drug resistance,
which is a particular concern with respect to the malaria parasite.
We note that the rapid death of the TgAPT mutant strongly
suggests that delayed death is not an inevitable outcome of inter-
ference with the apicoplast. Careful genetic and biochemical
analyses should yield a more detailed understanding of the truly
essential functions of this unique organelle and produce a list of
targets that are unique to the parasite and for which inhibition
results in the rapid demise of the pathogen.
EXPERIMENTAL PROCEDURES
Cosmid Recombineering
We constructed plasmids as templates from which to PCR amplify inserts that
we could then recombineer into cosmids. We designed vectors containing
T. gondii knockout cassettes, using both chloramphenicol and phleomycin
as selectable markers. We also designed vectors to enable 30-HA epitope
tagging of genes of interest. In our initial experiments, we noted that employing
the frequently used untranslated regions from the SAG1 and DHFR-TS genes,
which are also found in the backbone of the two cosmid libraries, interferes
with the efficiency of recombineering. We therefore developed constructs
using the flanking regions of the GRA1 and HXGPT genes (see Supplemental
Information for detail on cloning procedures).
Cosmid PSBYL85 was introduced into EL250 cells by electroporation (ECM
630, 1 mm cuvette, 1.75 kV, 250 U, and 25 mF; BTX; Holliston, MA), and
bacteria were grown on LB plates containing 50 mg/ml kanamycin (note that
EL250 cells should not be grown at temperatures above 30C). Clones were
picked, confirmed, and grown in liquid culture to an OD600 of 0.4, heat-
shocked for 20 min at 43C, and rendered electrocompetent. Modification
cassettes were amplified from either plasmid piCG or pHcG, flanked with
50 bp of gene-specific sequence in the primer. The PCR product was
introduced by electroporation, and cells were selected on agar using 50 mg/ml
kanamycin and 10 mg/ml gentamycin. A detailed protocol for cosmid recom-
bineering and schematic maps of the available tags and libraries (Figure S7)
can be found in the Supplemental Information.
Targeting the TgAPT Locus
Parasites were maintained and genetically manipulated as described (Striepen
and Soldati, 2007). We subcloned the coding sequence for TgAPT from a
vector kindly provided by Manami Nishi and David Roos (University of
Pennsylvania) into pDt7s4H3 (S. Ramakrishnan and G.G.v.D., unpublished
data) to generate a vector that expresses APT from a tetracycline-inducible
promoter with a 33 HA tag at the 30 end of the gene. We transfected this into
transactivator strain parasites (TATi) (Meissner et al., 2002) and selected with
pyrimethamine. A clonal line was isolated and transfected with 25–75 mg
TgAPT-KO cosmid. Note that we found that linearizing cosmids by restriction
did not increase transformation efficiency or the frequency of successful
gene targeting. We therefore use unrestricted cosmids for transfection.
JC-1 Labeling and Flow Cytometry
Parasites were harvested from infected host cells by needle passage and filtra-
tion, washed in phenol red-free medium, and adjusted to 2.5 3 107 cells/ml.CellWhere appropriate, we added valinomycin and carbonyl cyanide 3-chlorophe-
nylhydrazone (CCCP) to final concentrations of 10 mM. Parasites were
incubated at 37C for 30 min and JC-1 was added to a final concentration of
1.5 mM, followed by incubation for 15 min at 37C. Cells were washed and
analyzed by flow cytometry or microscopy. Flow cytometry was performed
on a FACSCalibur cytometer (Becton Dickinson; San Jose, CA).
Microscopy
Immunofluorescence assays were performed as previously described (van
Dooren et al., 2008). We used anti-HA antibodies (Roche; Indianapolis, IN) at
a dilution of 1:100, anti-Cpn60 (Agrawal et al., 2009) at a dilution of 1:2000,
and anti-ATrx1 (a kind gift from Peter Bradley, UCLA) at a dilution of 1:1000.
Fluorescence images were acquired using a Delta Vision or a Leica DM
IRBE microscope.
Western Blotting and Pulse-Chase Analyses
Western blotting was performed as previously described (van Dooren et al.,
2008). We used anti-HA antibodies at a dilution of 1:100, anti-ACP (a kind
gift from Geoff McFadden, University of Melbourne) (Waller et al., 1998) at
1:500, anti-GRA8 (a kind gift from Gary Ward, University of Vermont) (Carey
et al., 2000) at 1:2000, and anti-lipoylated-PDH-E2 (clone3H-2H4; a kind gift
from Eric Gershwin, University of California, Davis) (Migliaccio et al., 1998) at
1:1000. Pulse-chase analyses were performed as described previously (van
Dooren et al., 2008), with the modification that experiments were performed
in T75 flasks and the chase time was extended to 3 hr.
Heterologous Expression of the TgAPT in Yeast and Isolation
of Membrane Proteins
The coding sequence of TgAPT was amplified from RH strain cDNA and subcl-
oned into yeast pYES2/NTC vector (Invitrogen; Carlsbad, CA), resulting in
N- and C-terminal fusions, respectively. These plasmids were transformed
into the yeast strain InvSc1. For membrane preparation, cells were grown in
liquid media to an OD600 of 0.8–1.0. Expression was induced by resuspension
in liquid media containing 2% galactose. Cells were harvested after 6–8 hr and
stored at 20C. After thawing, cells were disrupted in a buffer containing
10 mM Tris-HCl (pH 7.5), 1 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride
(PMSF). Cell debris was removed by centrifugation for 1 min at 5003 g, and
total membranes were collected by centrifugation for 20 min at 100,0003 g.
Reconstitution and Measurement of Transport Activities
Liposomes were prepared from acetone-washed phosphatidylcholine (120–
130 mg/ml) by sonication for 4 min on ice in 100 mM Tricine-KOH (pH 7.6)
and 60 mM potassium gluconate (buffer A) in absence or presence of
20 mM of substrate, as indicated. Yeast membranes were solubilized using
100 ml 1.25% (w/v, final concentration) Triton X-100 as detergent and directly
added to 750 ml liposomes, and proteins were integrated into liposomes by a
freeze-thaw step. After sonication, the external medium was removed by
passage over Sephadex G-25 columns, and proteoliposomes were eluted
with buffer A. The transport experiments were started by addition of [32P]Pi
(0.2–10 mM) as the external counter-exchange substrate and terminated at
different time points (15–120 s) by passing the liposomes over a Dowex
AG1-X8 anion exchange column. The radioactivity of the eluate was deter-
mined by liquid scintillation counting. Background activity for membranes
purified from yeast transfected with empty plasmid was measured (typically
1% of TgAPT activity) and subtracted from all measurements.
SUPPLEMENTAL INFORMATION
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